A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients - Test2 - elhamkhani - TriplyDB

A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients

A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients

http://www.wikidata.org/entity/Q28477202

about

Helicobacter pylori infection and gastric carcinoma: Not all the strains and patients are alike Molecular classification and prediction in gastric cancer Systems biology of cisplatin resistance: past, present and future Normal fibroblasts induce E-cadherin loss and increase lymph node metastasis in gastric cancer Sky1 regulates the expression of sulfur metabolism genes in response to cisplatin Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview.Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer.Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.Hsp90 regulation of mitochondrial protein folding: from organelle integrity to cellular homeostasis Genotypes of cancer stem cells characterized by epithelial-to-mesenchymal transition and proliferation related functions.Gastric cancer-molecular and clinical dimensions.Eukaryotic translation initiation factor 3 subunit D overexpression is associated with the occurrence and development of ovarian cancer TRAP-1, the mitochondrial Hsp90.Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer.Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents.The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer.Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression.Knockdown of eukaryotic translation initiation factor 3 subunit D (eIF3D) inhibits proliferation of acute myeloid leukemia cells.Elemene Induces Apoptosis of Human Gastric Cancer Cell Line BGC-823 via Extracellular Signal-Regulated Kinase (ERK) 1/2 Signaling Pathway HNRNPC as a candidate biomarker for chemoresistance in gastric cancer.Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products.A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.Upregulation of periostin prevents P53-mediated apoptosis in SGC-7901 gastric cancer cells.MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors.BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin Eukaryotic translation initiation factors and cancer.Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy.SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment.High expression of eIF3d is associated with poor prognosis in patients with gastric cancer.Combination of TNM staging and pathway based risk score models in patients with gastric cancer.ADRM1 gene amplification is a candidate driver for metastatic gastric cancers.Genetic aspects of gastric cancer instability.Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer.

P2860

Q26769946-3A38D5A1-62CC-4268-92A7-E29111CB146F Q26783806-6F7E7184-8697-4563-A3B8-B5909E2B7EB6 Q26863585-95E0317B-8F4A-4A97-928E-DE26B0203D30 Q27332390-F28072F0-C332-4FF8-8021-FBB73D2B0D34 Q28389083-44524DAC-78A9-46F8-A984-4F6FF06D8E3A Q33737290-62E96552-EC51-4B32-B4CC-F3D5DB5BC427 Q33829437-EB5EA401-0D38-4252-908B-A71B9ADF8C72 Q33920296-87E61F1F-AAD9-4A9C-97B9-C80F2D1D94A5 Q34706800-DB1412EA-024F-4C3A-9608-FCB016E6C7A1 Q35712961-AD9C88E5-1E2E-48B9-97DF-B9A30F2EFEB9 Q36306149-99011AEB-4F88-4750-8046-03BF7B89DCCF Q36548702-50EB63E4-BE81-4C5A-BC62-D0C1178BDBF9 Q36962398-E44BC394-0EC3-43EA-B8A1-6FAA50C8C3E3 Q37056146-F415D3E0-75FD-45EB-B918-ED9302C77B5E Q37232663-3DFFBCF2-1E64-4FBF-B573-55DAAA029A15 Q37591176-DFD91A0B-BB22-4E19-BB77-D099B8A86427 Q37635646-31779130-BEC0-44AC-B3DE-C847879D53E5 Q37924023-1C389ED9-B47B-402A-89E2-2232F226E8DE Q38052406-D0CF32FA-00D0-45E4-8DCE-37B578DB301D Q38059212-C1B0CEE4-32B5-41AC-867C-78211E70077A Q38188598-3FF557DD-6A41-417D-8DC4-210C6F6A701A Q38297145-A4F45504-AF2D-4EF1-AD6C-DDB5EF985081 Q38630652-B5AB2377-DCA2-44CB-AB95-762CC0508A0E Q38695065-20D132DE-584C-4791-A360-D73B29CC952B Q38716546-E80078F2-8C8D-4683-ADC3-A0FF37F1255D Q38829125-F1F50AF8-8BD6-4643-8009-1A2D36F4B347 Q38871165-3A4EFBF2-A5E1-4271-B75E-2A7C3CDBD5E4 Q39063066-2C0A92A8-1A0B-4C3A-987E-D25AC6311AF3 Q39077324-17934D9B-3F96-433A-A04A-0C4BD2B6F921 Q39257443-8FADC7FE-CE48-4E5C-8C0C-4315A92E15B8 Q39372689-C266C6D4-C449-4F99-AE9F-831D8FA27206 Q39392319-F351DE8C-7CAE-44E4-85A2-D4919AC5555C Q39400409-902FE565-A523-4079-8596-B82FE62A863A Q39590420-706382A2-B81D-4AE4-A0AB-371282A436CD Q40007032-AC218553-CF27-4975-94E7-437498F99788 Q45853358-37DF59CF-D738-45FF-AD45-3817D7B5F841 Q48134310-EF11DA17-510B-42CB-A7DC-4F1BBCCD563C Q53038879-EB728823-2EA7-4B0F-935A-D609C136285A Q53270206-4981E618-E160-4469-A60D-1E02222BC7CE Q55315465-56B12187-3D3C-46A2-9617-18937A700FAE

P2860

A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients

http://www.wikidata.org/entity/Q28477202

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A gene expression signature of ...... apy in gastric cancer patients

@ast

A gene expression signature of ...... apy in gastric cancer patients

@en

A gene expression signature of ...... apy in gastric cancer patients

@nl

type

label

A gene expression signature of ...... apy in gastric cancer patients

@ast

A gene expression signature of ...... apy in gastric cancer patients

@en

A gene expression signature of ...... apy in gastric cancer patients

@nl

prefLabel

A gene expression signature of ...... apy in gastric cancer patients

@ast

A gene expression signature of ...... apy in gastric cancer patients

@en

A gene expression signature of ...... apy in gastric cancer patients

@nl

P1433

Q28477202-344F94F4-2BD2-4676-87FB-B82BF4263D2F

P1476

Q28477202-CEE0706E-8DAA-4D98-A4C6-E116110FEC30

P2093

Q28477202-195CD6E1-D190-4228-9043-27CD499F8C2C

Q28477202-1D9904ED-B7C2-48CD-8696-BC4FC910B9C4

Q28477202-347B478D-923F-435E-B9C5-E16EC40448EA

Q28477202-4E0CA528-5175-4B4A-AB99-637C57DC5185

Q28477202-A5F75EC3-E051-4853-A980-5A7E83630140

Q28477202-B1B4E9B1-5F58-497A-8EDC-856583C7AD24

Q28477202-BC555391-9F82-4949-85D2-5AC1C2C2EFD2

P2860

Q28477202-0254DD33-F4B1-4202-A3B4-C6C978DE7304

Q28477202-0AA7249E-0C5E-4CBA-A1DF-E347C3B9F3D5

Q28477202-11E8347C-DC07-4E04-9FC9-DC9892B06127

Q28477202-1304E694-8EA8-451F-9BCB-DD3E47F7512E

Q28477202-18F106E6-2465-4754-A453-2C1578D1D127

Q28477202-23412170-671A-4987-A2F9-81819AC5AD6D

Q28477202-27F0DC3C-D9F3-437A-838C-A02B5FAA8EA1

Q28477202-2ADC1137-9BEB-4675-BF31-ED14EA728DFF

Q28477202-2CA50F64-F11F-4FA6-9696-D4E0100C3679

Q28477202-3F22F3FB-8F7A-48B7-9B3A-579645F74B9A

P304

Q28477202-CCE1FB7E-F35B-49CA-935E-97EC475E87F8

P31

Q28477202-631E30B2-EDA1-4587-BB9B-4594BED51AE3

P3181

Q28477202-E5FCECB0-6072-410A-8E74-0A7D4093B043

P356

Q28477202-75C9D1E2-5962-47ED-ABE9-25B61FE6920F

P407

Q28477202-D0369F22-1241-46A7-89D5-40C069BAEB0A

P433

Q28477202-AE59E59F-8D47-47F4-8EF3-1D656935D966

P478

Q28477202-4DFBA89D-97E1-464A-970E-77325B3031A0

P577

Q28477202-DDEE313B-F877-47C8-BCA9-EEA797AB11C6

P5875

Q28477202-B689D183-BB1C-488B-AEB5-3671FD264F06

P698

Q28477202-E6803AA9-5082-4C1E-B79E-7CACDE320298

P921

Q28477202-8370EF1F-70A8-4B11-91ED-E0681D9C73A2

Q28477202-F68B23D6-1C2E-44C5-B722-894068B4E8DD

P932

Q28477202-26CA7C5C-05C6-4D85-BC3A-DDE706454953

P3181

P356

JOURNAL.PONE.0016694

P1433

P1476

A gene expression signature of ...... apy in gastric cancer patients

@en

P2093

Akira Oshima

http://www.w3.org/2001/XMLSchema#string

Aleksandra Michalowski

http://www.w3.org/2001/XMLSchema#string

Chan Gyoo Kim

http://www.w3.org/2001/XMLSchema#string

Hark Kyun Kim

http://www.w3.org/2001/XMLSchema#string

Hee Sung Kim

http://www.w3.org/2001/XMLSchema#string

Il Ju Choi

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Green

http://www.w3.org/2001/XMLSchema#string

P2860

A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells

The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity

Core transcriptional regulatory circuitry in human embryonic stem cells

Characterization of clonogenic multiple myeloma cells

TRED: a Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies

Semi-supervised methods to predict patient survival from gene expression data

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer.

Missing value estimation methods for DNA microarrays

Control of developmental regulators by Polycomb in human embryonic stem cells

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties

P304

e16694

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3669626

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0016694

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50250671

http://www.w3.org/2001/XMLSchema#string

P698

21364753

http://www.w3.org/2001/XMLSchema#string

P921

P932

3041770

http://www.w3.org/2001/XMLSchema#string